v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities        
Net income (loss) $ (4,177) $ (934) $ (10,147) $ (7,639)
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Net realized (gains) losses on investments     1,876 1,996
Net realized (gains) losses on foreign currency     0 11
Net change in unrealized (gains) losses on investments     11,995 (7,316)
Net change in unrealized (gains) losses on foreign currency     0 (36)
Change in fair value of debt obligation     0 (1,339)
Payment in-kind interest     498 144
Equity investment earnings     (515) (324)
Amortization of debt issuance costs     123 251
Amortization of deferred acquisition costs     1,411 1,460
Amortization of intangible assets     1,118 2,799
Net amortization of premiums and accretion of discounts on investments     (241) 177
Equity based compensation     79 643
Increase (decrease) in estimated credit losses     (3,136) 218
Write-off of unamortized debt issuance costs     472 0
(Increase) decrease in operating assets:        
Reinsurance recoverable     734 3,623
Change in deferred acquisition costs     (88) (3,393)
Distributions from equity method investments     1,762 892
Purchases of investments by consolidated VIEs     (51,579) (33,952)
Proceeds from sale of investments by consolidated VIEs     37,107 30,932
Increase (decrease) in operating liabilities:        
Due to related parties     1,689 3,086
Future policy benefits     (24,127) (8,903)
Interest sensitive contract liabilities     8,468 7,815
Funds held under reinsurance contracts     (4,217) (2,637)
Accrued expenses and other liabilities     (3,114) 5,619
Net cash used in operating activities     (31,516) (6,993)
Investing Activities        
Purchases of investments     (191,006) (130,680)
Proceeds from sales and repayments of investments     188,588 147,725
Net cash provided by (used in) investing activities     (2,418) 17,045
Financing Activities        
Shareholder dividends     (669) (809)
Repurchase of common shares     (15,467) 0
Proceeds from borrowings of asset management business     45,597 0
Repayments of borrowings of asset management business     (24,000) (768)
Financing costs paid and deferred     (2,309) 0
Proceeds from borrowings of insurance business     0 3,000
Repayments of borrowings of insurance business     (5,250) 0
Deposits on investment-type policies and contracts     0 42,996
Withdrawals on investment-type policies and contracts     (15,387) (22,403)
Net cash provided by (used in) financing activities     (17,485) 22,016
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation    
Supplemental disclosures of cash flow information        
Interest received     39,128 44,178
Interest paid     4,228 3,431
Dividends received     318 742
Income taxes paid     $ 64 $ 243
Supplemental Disclosures of Non-Cash Investing and Financing Activities        
Issuance of common shares for vested Restricted Share Units (in shares)     0 209
Issuance of common shares for investment purchases (in shares)     0 5,000
Issuance of common shares for share based compensation (in shares)     0 45
Variable Interest Entity, Primary Beneficiary        
(Increase) decrease in operating assets:        
Other assets     $ 90 $ (96)
Financing Activities        
Net increase (decrease) in cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs     (51,419) 32,068
Cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs, beginning of the period     143,725 101,704
Cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs, end of period 92,306 133,772 92,306 133,772
Consolidated Entity, Excluding Consolidated VIE        
(Increase) decrease in operating assets:        
Other assets     (1,774) (1,024)
Asset Management        
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Net realized (gains) losses on investments 0 (22) (367) (81)
Net change in unrealized (gains) losses on investments 967 (845) 1,690 (1,627)
Equity investment earnings (153) (42) (515) (324)
Financing Activities        
Cash and cash equivalents 4,774 2,748 4,774 2,748
Insurance Solutions        
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Amortization of deferred acquisition costs 703 905 1,411 1,460
Financing Activities        
Cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs, end of period 87,532 131,024 87,532 131,024
Restricted cash 11,640 11,258 11,640 11,258
Supplemental disclosures of cash flow information        
Interest paid 600 400 900 700
Insurance Solutions | Variable Interest Entity, Primary Beneficiary        
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Net realized (gains) losses on investments (59) (177) 647 (237)
Net change in unrealized (gains) losses on investments 1,269 464 4,240 789
Financing Activities        
Cash and cash equivalents 16,029 22,233 16,029 22,233
Insurance Solutions | Consolidated Entity, Excluding Consolidated VIE        
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Net realized (gains) losses on investments 389 1,908 1,596 2,325
Net change in unrealized (gains) losses on investments (2,277) (6,006) 6,065 (7,853)
Financing Activities        
Cash and cash equivalents $ 59,863 $ 97,533 $ 59,863 $ 97,533